2019

US Patent granted for all neuro-muscular conditions

FDA filing for JOGO - Gx

Launch clinical trials  for three conditions

2020

JOGO-Gx FDA 510(K) Exemption Received, April 2020

Post stroke plantar flexor spasticity and ankle dorsiflexion recovery

Chronic lower back pain

Post COVID-19 Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

2021

Migraine and Tension Headache

Fibromyalgia

Urinary Incontinence

Constipation

2022

Migraine

Needle-less EMG Nerve Conduction Testing

Fecal Incontinence

Premature Ejaculation

2025

Cerebral Palsy, Sleep bruxism, Patellofemoral pain syndrome, Swallowing disorder (dysphagia)  Pain relief in cancer patients , temporomandibular disorders ,vulvar vestibulitis, subacromial impingement syndrome

© 2020 BY JOGOHEALTH | PRIVACY POLICY

JOGO-Gx is FDA 510 (K) Exempt. FDA registration number.: 3016735640.

FDA Owner Operator Number: 10069814

US Group National Provider Number (NPI) 1013537349